Ensuring Essential Medicines Satisfy Priority Healthcare Needs of Populations

This report looks at the current state and future direction of essential medicines on the World Health Organization’s Model Essential Medicines List, as well as approaches that health systems that include these essential medicines into their own lists can take to ensure EMs achieve their full potential benefit to populations. This report takes a closer look at general health system elements to support the appropriate use and wider access to EMs—such as healthcare infrastructure, procurement and supply-chain capabilities, financial support, etc.—as well as therapy-specific requirements for infectious and non-communicable diseases such as specialized healthcare professionals and facilities and diagnostic capabilities. The report studies EMs that target eight diseases in seven countries—Brazil, China, India, Indonesia, Kenya, Mexico and South Africa—and examines EM usage and the level of level of specific therapy area support. This study was conducted independently by the QuintilesIMS Institute with funding support from the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).

 Download Report